Showing 1 - 20 results of 21,759 for search '(( 59 ((a decrease) OR (_ decrease)) ) OR ((( 5 w decrease ) OR ( 5 wt decrease ))))*', query time: 0.80s Refine Results
  1. 1
  2. 2
  3. 3

    Brain and liver GCase activity are significantly decreased in heterozygous <i>GBA1</i> D409V KI mice, with varying differences in glucosphingolipid lipids in brain and liver. by Nicole K. Polinski (10947787)

    Published 2021
    “…(A-B) GCase levels as assessed by the CBE/4-MU method are significantly decreased in the het <i>GBA1</i> D409V KI mice at 5 months of age in both brain (A) and liver (B). …”
  4. 4

    GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

    Published 2021
    “…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”
  5. 5
  6. 6

    Baseline sleep/wake characterizations of WT and W/W<sup>v</sup> mice. by Sachiko Chikahisa (417256)

    Published 2013
    “…Amount of REM (bottom) was slightly decreased in W/W<sup>v</sup> mice during the light phase (L; ZT0-12) but was not during the dark phase (D; ZT12-24). …”
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    The effects of thioperamide and alpha-FMH on the amount of sleep/wake in WT and W/W<sup>v</sup> mice. by Sachiko Chikahisa (417256)

    Published 2013
    “…<p>(A) Injection of thioperamide (ip), a H3 antagonist, at a high dose (10 mg/kg) increased wakefulness in both WT and W/W<sup>v</sup> mice for 3 hours. (B) In contrast, injection of alpha-FMH (ip), a HDC blocker, at medium (50 mg/kg) and high (100 mg/kg) doses decreased the amount of wakefulness in WT mice. …”
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20